Exagen does it again! Their Lupus AVISE testing will now be considered in-network for 3 medical groups! Yay!

Happy to share the following: 

Exagen is pleased to announce contracts with three large medical groups across California to offer AVISE® testing as a covered in-network benefit for patients suspected of having autoimmune disease. Visit Exagen's website to view the press release, or click here to find out more about the AVISE testing. 

Interestingly, this announcement comes on the heels of my participation in a Lupus Strategy Session for National Quality Forum's Measure Incubator, sponsored by Johnson and Johnson. I was honored to be part of the expert panel whose goal was to explore ideas to improve the quality of healthcare in lupus patients. It was wildly productive!  

During the session, discussion about improving the time to lupus diagnosis as well as monitoring the use of plaquenil came up in discussion. The AVISE testing is relevant in both areas, as Exagen has created blood tests specifically for lupus diagnosis and testing hydroxychloroquine levels. But it's clear that one obstacle in allowing the testing to become readily available is insurance coverage. 

So this is big! Three steps forward for Exagen, and a giant step forward for lupus diagnoses!  


Popular Posts